THE COURSE OF STABLE CORONARY ARTERY DISEASE COMBINED WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN THE REHABILITATION PERIOD AFTER REVASCULARIZATION PROCEDURES

Authors

  • I. I. Vakaliuk Ivano-Frankivsk National Medical University
  • N. H. Virstiuk Ivano-Frankivsk National Medical University

DOI:

https://doi.org/10.11603/2415-8798.2016.4.7137

Keywords:

stable coronary heart disease, non-alcoholic fatty liver disease, myocardial revascularization.

Abstract

The course of stable coronary artery disease combined with non-alcoholic fatty liver disease in the rehabilitation period after revascularization procedures – The aim of study was to evaluate the course of stable coronary heart disease (CHD) combined with non-alcoholic fatty liver disease (NAFLD) in the rehabilitation period after revascularization procedures. 220 patients with stable CHD combined with NAFLD, including 80 patients after revascularization procedures were examined. All patients were conducted general clinical and functional methods of examination for verification of stable CHD and NAFLD. It was established more favorable course of stable CHD, concomitant heart failure and arterial hypertension combined with NAFLD after myocardial revascularization. It was determined that the clinical peculiarities of stable CHD combined with NAFLD were expressed by clinical symptoms of the main and comorbidity diseases, less pronounced after myocardial revascularization. It was proved that myocardial revascularization improves long-term prognosis in patients with stable CHD combined with NAFLD.

 

References

Otsinka poshyrenosti ta kontrolyu faktoriv ryzyku sertsevo-sudynnykh zakhvoryuvanʹ sered naselennya ta likariv / I. M. Horbasʹ, O. M. Barna, V. YU. Sakalosh [ta in.] // Liky Ukrayiny. – 2010. – № 1. – S. 4–9.

Fadyeyenko H. D. Komorbidna patolohiya, shcho vplyvaye na sertsevo-sudynnyy ryzyk u postinfarktnykh khvorykh / H. D. Fadyeyenko, V. A. Chernyshov // Ukrayinsʹkyy terapevtychnyy zhurnal. – 2014. – № 2. – S. 11–20.

Suspected nonalcoholic fatty liver disease and mortality risk in a population–based cohort study / W. Dunn, R. Xu, D. Wingard [et al.] // Am. J. Gastroenterol. – 2008. – Vol. 103. – P. 2263–2271.

Endpoints and clinical trial design for non–alcoholic steatohepatitis. / A. J. Sanyal, E. M. Brunt, D. E. Kleiner [et al.] // Hepatology. – 2011. – Vol. 54. – P. 344–353.

Bazylevych A. YA. Nealkoholʹnyy steatohepatyt yak novyy faktor rozvytku ishemichnoyi khvoroby sertsya / A. YA. Bazylevych // Scientific Journal “ScienceRise”. – 2015. – № 10/3(15). – S. 171–175.

Santoro, N. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Obese Adolescents: A Looming Marker of Cardiac Dysfunction / N. Santoro, S. Caprio // Hepatology. – 2014. – Vol. 59, Issue 2. – R. 372–374.

Vdovychenko V. I. Poshyrenistʹ nealkoholʹnoyi zhyrovoyi khvoroby pechinky sered pomerlykh, yaki strazhdaly na tsukrovyy diabet 2 typu / V. I. Vdovychenko, KH. B. Aksentiychuk // Suchasna hastroenterolohiya. – 2013. – № 1 (69). – S. 41–46.

Horbasʹ I. M. Ishemichna khvoroba sertsya: epidemiolohiya i statystyka / I. M. Horbasʹ // Zdorovʺya Ukrayiny. – 2009. – № 3. – S. 34–35.

Zvyahyntseva T. D. Khronycheskye dyffuznye zabolevanyya pecheny sochetannoy étyolohyy: podkhody k lechenyyu s pozytsyy dokazatelʹnoy medytsyny / T. D. Zvyahyntseva, A. Y. Chernobay // Zdorovʺya Ukrayiny. – 2011. – № 11–12. – S. 50–51.

Semendyaeva M. E. Nealkoholʹnaya zhyrovaya boleznʹ pecheny kak medytsynskaya y sotsyalʹnaya problema / M. E. Semendyaeva // Klynycheskaya praktyka. – 2012. – № 2. – S. 71–80.

Angulo P. Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance? / P. Angulo // Hepatology. – 2010. – Vol. 51 (2). – R. 373–375.

Association between nonalcoholic fatty liver disease and coronary artery calcification / C. H. Chen, C. K. Nien, C. C. Yang [et al.] // Dig. Dis. Sci. – 2010. – Vol. 55 (6). – R. 1752–1760.

The metabolic syndrome and cardiovascular risk: a systematic review and meta-analysis // J. Amer. Coll. Cardiol. – 2010. – Vol. – 56 (14). – P. 1113–1132.

Dolzhenko M. M. Vplyv nealkoholʹnoyi zhyrovoyi khvoroby pechinky na perebih ishemichnoyi khvoroby sertsya za danymy dvorichnoho sposterezhennya / M. M. Dolzhenko, A. YA. Bazylevych, N. M. Nosenko // Ukrayinsʹkyy kardiolohichnyy zhurnal. – 2011. – № 2. – 67–70.

A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patient /M. C. Guilherme, B. Kiran [et al.] // Hepatology. – 2008. – Vol. 47 (6). – P. 1916–1923.

Presence of coronary plaques in patients with nonalcoholic fatty liver disease / N. Assy, A. Djibre, R. Farah [et al.] // Radiology. – 2010. – Vol. 254 (2). – P. 393–400.

Carmelo A. C. Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern italy / A. C. Carmelo, M. P. Gaspare // Amer. J. Epidemiol. – 2010 – Vol. 171 (11). – R. 1195–1202.

Unifikovanyy klinichnyy protokol “Stabilʹna ishemichna khvoroba sertsya” / V. V. Kravchenko, M. YU. Sokolov, T. V. Talayeva [ta in.]. – Nakaz MOZ Ukrayiny № 152 vid 02.03.2016 roku.

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association / N. Chalasani, Z. Younossi, J. E. Lavine [et al.] // Hepatology. – 2012. – Vol. 55, № 6. – P. 2005–2023.

Unifikovanyy klinichnyy protokol “Nealkoholʹnyy steatohepatyt” / M. K. Khobzey, N. V. Kharchenko, O. M. Lishchyshyna [ta in.]. – Nakaz MOZ Ukrayiny № 826 vid 06.11.2014 roku.

Published

2017-02-09

How to Cite

Vakaliuk, I. I., & Virstiuk, N. H. (2017). THE COURSE OF STABLE CORONARY ARTERY DISEASE COMBINED WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN THE REHABILITATION PERIOD AFTER REVASCULARIZATION PROCEDURES. Bulletin of Scientific Research, (4). https://doi.org/10.11603/2415-8798.2016.4.7137

Issue

Section

INTERNAL MEDICINE